Report of Foreign Issuer (6-k)
March 08 2018 - 11:44AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form
6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE
13a-16
OR
15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2018
Commission File Number:
001-32001
Aptose Biosciences Inc.
(Translation of registrant’s name into English)
5955 Airport
Road, Suite 228
Mississauga, Ontario L4V 1R9
Canada
(Address of
principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form
20-F
or Form
40-F.
Form
20-F ☐ Form
40-F ☑
Indicate by check mark if the registrant is submitting the Form
6-K
in paper as permitted by
Regulation
S-T
Rule 101(b)(1) ☐
Indicate by check mark if the registrant is
submitting the Form
6-K
in paper as permitted by Regulation
S-T
Rule 101(b)(7) ☐
INCORPORATION BY REFERENCE
Exhibit 99.1 to this Report on Form
6-K
is hereby incorporated by reference as an Exhibit to the
Registration Statement on Form
F-10
of Aptose Biosciences Inc. (File
No. 333-222909).
DOCUMENTS FILED AS PART OF THIS FORM
6-K
See the Exhibit Index hereto.
SIGNATURES
Pursuant to
the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
Aptose Biosciences Inc.
|
|
|
|
|
|
|
Date: March 8, 2018
|
|
|
|
By:
|
|
/s/ Gregory Chow
|
|
|
|
|
|
Name:
|
|
Gregory Chow
|
|
|
|
|
|
Title:
|
|
Senior Vice President and Chief Financial Officer
|
2
EXHIBIT INDEX
Aptose Biosciences (NASDAQ:APTO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aptose Biosciences (NASDAQ:APTO)
Historical Stock Chart
From Apr 2023 to Apr 2024
